Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JOYROX-LS is a combination pharmaceutical product marketed by JoY Pharma, a Bengaluru-based pharmaceutical company. It is categorized within the anti-allergic, cold, cough, and flu range. The formulation is a branded generic typically used to treat productive cough associated with respiratory conditions like bronchitis, bronchial asthma, and chronic obstructive pulmonary disease (COPD). It contains three active small molecule ingredients: levosalbutamol, a bronchodilator that acts as a selective beta-2 adrenergic receptor agonist to relax airway muscles; ambroxol, a mucolytic agent that thins and loosens phlegm; and guaifenesin, an expectorant that promotes the clearance of mucus by increasing the volume of airway secretions. This combination therapy is designed to facilitate easier breathing and effective expectoration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on JOYROX-LS.